In 1947, the privately-held multinational company Kowa Company, Ltd. of Nagoya, Japan, established its pharmaceutical division in order to research, develop, manufacture and market over-the-counter (OTC) drugs, healthcare products, prescription medicines and medical devices.

Kowa’s wide variety of prescription medicines include oral agents for the treatment of cardiovascular diseases as our specialty segments, topical agents for eye and skin, and agents affecting the digestive organs.

Work with us

For more information on our partnership opportunities please get in touch

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

Contact us

    I confirm I have read and accept the terms of the Privacy policy